RT Journal Article SR Electronic T1 Cardiovascular risk reduction in diabetes: underemphasised and overdue. Messages from major trials JF Clinical Medicine JO Clin Med FD Royal College of Physicians SP 472 OP 477 DO 10.7861/clinmedicine.1-6-472 VO 1 IS 6 A1 Amanda I Adler YR 2001 UL http://www.rcpjournals.org/content/1/6/472.abstract AB Diabetes markedly increases the risk of coronary artery disease and death, but is underrecognised as a cardiovascular risk factor, despite the existence of effective treatments. Because patients with diabetes are at high risk for coronary disease, they have more to gain from prevention. There is evidence from clinical trials that select cardiovascular therapies may work better in diabetes, beyond their expected benefit, and may prevent diabetes itself.